Skip to content
ClinCalc Pro
Menu
Antihistamine + Sympathomimetic (Topical Ophthalmic)

Antazoline with Xylometazoline

Brand names: Otrivine-Antistin

Antazoline with xylometazoline is a topical ocular preparation combining an antihistamine with a sympathomimetic vasoconstrictor, used for short-term relief of allergic conjunctivitis.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

Antazoline blocks histamine H1 receptors to reduce itch and inflammation, while xylometazoline stimulates alpha-adrenergic receptors to constrict conjunctival vessels and reduce redness.

Prescribing in practice

  • Avoid in untreated angle-closure (narrow-angle) glaucoma, as the sympathomimetic component can precipitate an acute attack.
  • Limit to short-term use, as prolonged application of the vasoconstrictor can cause rebound conjunctival hyperaemia.
  • Use with caution in patients with cardiovascular disease, hypertension or hyperthyroidism.

Monitoring

Monitor symptomatically for resolution of allergic signs and for rebound redness with continued or prolonged use.

Counselling the patient

  • Use for only a few days; if symptoms persist, seek further review.
  • Remove contact lenses before instilling drops.
  • Transient stinging and pupil changes can occur after instillation.

Evidence & guidelines

Combined antihistamine-decongestant eye drops provide established short-term symptomatic relief in allergic conjunctivitis as reflected in current prescribing references.

Reference: NICE CKS Conjunctivitis — allergic (2023); RCOphth patient information; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.